Related references
Note: Only part of the references are listed.Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
Mahmood Rasool et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Targeted therapy: tailoring cancer treatment
Min Yan et al.
CHINESE JOURNAL OF CANCER (2013)
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
Ana R. Gomes et al.
CHINESE JOURNAL OF CANCER (2013)
Deubiquitinases in cancer: new functions and therapeutic options
J. M. Fraile et al.
ONCOGENE (2012)
Spotlight on the role of COP1 in tumorigenesis
Jean-Christophe Marine
NATURE REVIEWS CANCER (2012)
Pharmacogenetics: past, present and future
Munir Pirmohamed
DRUG DISCOVERY TODAY (2011)
WHAT GENETICS TELLS US ABOUT THE CAUSES AND MECHANISMS OF PARKINSON'S DISEASE
Olga Corti et al.
PHYSIOLOGICAL REVIEWS (2011)
Coordinated Chromatin Control: Structural and Functional Linkage of DNA and Histone Methylation
Xiaodong Cheng et al.
BIOCHEMISTRY (2010)
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
Shelly S. Lo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epigenetics: A New Bridge between Nutrition and Health
Sang-Woon Choi et al.
ADVANCES IN NUTRITION (2010)
DUBs and cancer The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
Sajjad Hussain et al.
CELL CYCLE (2009)
Epigenetic mechanisms in mammals
J. K. Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Ubiquitin ligase ARF-BP1/Mule modulates base excision repair
Jason L. Parsons et al.
EMBO JOURNAL (2009)
Epigenetics and human disease
Martin Hirst et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
Patrick O. McGowan et al.
NATURE NEUROSCIENCE (2009)
Genomic and personalized medicine: foundations and applications
Geoffrey S. Ginsburg et al.
TRANSLATIONAL RESEARCH (2009)
Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation
Guy Froyen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Epigenetics and the Nervous System
Mark F. Mehler
ANNALS OF NEUROLOGY (2008)
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
B. Sadikovic et al.
CURRENT GENOMICS (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Persistent epigenetic differences associated with prenatal exposure to famine in humans
Bastiaan T. Heijmans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes
Nikolay Tzvetkov et al.
BIOLOGICAL CHEMISTRY (2007)
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Tarjei S. Mikkelsen et al.
NATURE (2007)
Phenotypic plasticity and the epigenetics of human disease
Andrew P. Feinberg
NATURE (2007)
Primer: epigenetics of autoimmunity
Bruce Richardson
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Environmental epigenomics and disease susceptibility
Randy L. Jirtle et al.
NATURE REVIEWS GENETICS (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Clinical implications of pharmacogenomics of statin treatment
L. M. Mangravite et al.
PHARMACOGENOMICS JOURNAL (2006)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Embracing the complexity of genomic data for personalized medicine
M West et al.
GENOME RESEARCH (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Genomic medicine: genetic variation and its impact on the future of health care
HF Willard et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2005)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
JC Byrd et al.
BLOOD (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Membrane transporters and channels:: Role of the transportome in cancer chemosensitivity and chemoresistance
Y Huang et al.
CANCER RESEARCH (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The origin of schizophrenia: Genetic thesis, epigenetic antithesis, and resolving synthesis
A Petronis
BIOLOGICAL PSYCHIATRY (2004)
An evaluation of new criteria for CpG islands in the human genome as gene markers
Y Wang et al.
BIOINFORMATICS (2004)
Epigenetics and bipolar disorder: New opportunities and challenges
A Petronis
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2003)
A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain
NJ Bray et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Potential role of pharmacogenomics in reducing adverse drug reactions - A systematic review
KA Phillips et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Identification of the familial cylindromatosis tumour-suppressor gene
GR Bignell et al.
NATURE GENETICS (2000)
Share Paper
